• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Incidence of Norovirus-Associated Acute Gastroenteritis across Age Groups in a Peruvian Andean Community.秘鲁安第斯社区各年龄组诺如病毒相关急性胃肠炎的发病率
Am J Trop Med Hyg. 2025 Jan 7;112(4):921-927. doi: 10.4269/ajtmh.24-0331. Print 2025 Apr 2.
2
High Prevalence and Genetic Diversity of Human Norovirus Among Children Under 5 Years Old with Acute Gastroenteritis at the Dr. Leonardo Guzmán Regional Hospital, Antofagasta, Chile, 2019.2019年智利安托法加斯塔莱昂纳多·古斯曼博士地区医院5岁以下急性胃肠炎儿童中人类诺如病毒的高流行率和基因多样性
Viruses. 2025 May 30;17(6):794. doi: 10.3390/v17060794.
3
Norovirus acute gastroenteritis amongst US and European travellers to areas of moderate to high risk of travellers' diarrhoea: a prospective cohort study.中美欧旅行者前往中高旅行者腹泻风险地区的诺如病毒急性胃肠炎:一项前瞻性队列研究。
J Travel Med. 2024 Oct 19;31(7). doi: 10.1093/jtm/taad051.
4
Norovirus in Latin America: Systematic Review and Meta-analysis.拉丁美洲的诺如病毒:系统评价与荟萃分析。
Pediatr Infect Dis J. 2017 Feb;36(2):127-134. doi: 10.1097/INF.0000000000001369.
5
Safety and efficacy of repeat ivermectin mass drug administrations for malaria control (RIMDAMAL II): a phase 3, double-blind, placebo-controlled, cluster-randomised, parallel-group trial.重复使用伊维菌素进行疟疾控制的安全性和有效性(RIMDAMAL II):一项3期、双盲、安慰剂对照、整群随机、平行组试验。
Lancet Infect Dis. 2025 Jul;25(7):737-750. doi: 10.1016/S1473-3099(24)00751-5. Epub 2025 Feb 4.
6
Burden of acute gastroenteritis caused by norovirus in China: A systematic review.中国诺如病毒急性胃肠炎负担:系统评价。
J Infect. 2017 Sep;75(3):216-224. doi: 10.1016/j.jinf.2017.06.004. Epub 2017 Jun 17.
7
A systematic review and meta-analysis of the prevalence of norovirus in cases of gastroenteritis in developing countries.发展中国家胃肠炎病例中诺如病毒流行率的系统评价和荟萃分析。
Medicine (Baltimore). 2017 Oct;96(40):e8139. doi: 10.1097/MD.0000000000008139.
8
Global burden and trends of norovirus-associated diseases from 1990 to 2021 an observational trend study.1990年至2021年诺如病毒相关疾病的全球负担及趋势:一项观察性趋势研究
Front Public Health. 2025 Jan 7;12:1483149. doi: 10.3389/fpubh.2024.1483149. eCollection 2024.
9
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
10
Surveillance for Violent Deaths - National Violent Death Reporting System, 50 States, the District of Columbia, and Puerto Rico, 2022.暴力死亡监测——2022年全国暴力死亡报告系统,50个州、哥伦比亚特区和波多黎各
MMWR Surveill Summ. 2025 Jun 12;74(5):1-42. doi: 10.15585/mmwr.ss7405a1.

本文引用的文献

1
Global and regional circulation trends of norovirus genotypes and recombinants, 1995-2019: A comprehensive review of sequences from public databases.全球和地区诺如病毒基因型和重组体的循环趋势,1995-2019:来自公共数据库序列的综合综述。
Rev Med Virol. 2022 Sep;32(5):e2354. doi: 10.1002/rmv.2354. Epub 2022 Apr 28.
2
Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.204 个国家和地区 1990-2019 年 369 种疾病和伤害导致的全球负担:2019 年全球疾病负担研究的系统分析。
Lancet. 2020 Oct 17;396(10258):1204-1222. doi: 10.1016/S0140-6736(20)30925-9.
3
Norovirus transmission mediated by asymptomatic family members in households.家庭中无症状家庭成员介导的诺如病毒传播。
PLoS One. 2020 Jul 23;15(7):e0236502. doi: 10.1371/journal.pone.0236502. eCollection 2020.
4
Updated classification of norovirus genogroups and genotypes.诺如病毒基因群和基因型的更新分类。
J Gen Virol. 2019 Oct;100(10):1393-1406. doi: 10.1099/jgv.0.001318.
5
Global Prevalence of Asymptomatic Norovirus Infection: A Meta-analysis.无症状诺如病毒感染的全球流行率:一项荟萃分析。
EClinicalMedicine. 2018 Sep 17;2-3:50-58. doi: 10.1016/j.eclinm.2018.09.001. eCollection 2018 Aug-Sep.
6
Progress on norovirus vaccine research: public health considerations and future directions.诺如病毒疫苗研究进展:公共卫生方面的考虑因素和未来方向。
Expert Rev Vaccines. 2018 Sep;17(9):773-784. doi: 10.1080/14760584.2018.1510327. Epub 2018 Aug 27.
7
Burden of Influenza in 4 Ecologically Distinct Regions of Peru: Household Active Surveillance of a Community Cohort, 2009-2015.秘鲁 4 个生态区的流感负担:2009-2015 年家庭对社区队列的主动监测。
Clin Infect Dis. 2017 Oct 16;65(9):1532-1541. doi: 10.1093/cid/cix565.
8
Incidence of Norovirus-Associated Diarrhea and Vomiting Disease Among Children and Adults in a Community Cohort in the Peruvian Amazon Basin.秘鲁亚马逊流域社区队列中儿童和成人的诺如病毒相关腹泻和呕吐疾病的发生率。
Clin Infect Dis. 2017 Sep 1;65(5):833-839. doi: 10.1093/cid/cix423.
9
Genetic and Epidemiologic Trends of Norovirus Outbreaks in the United States from 2013 to 2016 Demonstrated Emergence of Novel GII.4 Recombinant Viruses.2013年至2016年美国诺如病毒暴发的遗传和流行病学趋势表明新型GII.4重组病毒出现。
J Clin Microbiol. 2017 Jul;55(7):2208-2221. doi: 10.1128/JCM.00455-17. Epub 2017 May 10.
10
Norovirus in Latin America: Systematic Review and Meta-analysis.拉丁美洲的诺如病毒:系统评价与荟萃分析。
Pediatr Infect Dis J. 2017 Feb;36(2):127-134. doi: 10.1097/INF.0000000000001369.

秘鲁安第斯社区各年龄组诺如病毒相关急性胃肠炎的发病率

Incidence of Norovirus-Associated Acute Gastroenteritis across Age Groups in a Peruvian Andean Community.

作者信息

Campbell Wesley R, Neyra Joan, Calderwood Laura E, Romero Candice, Soto Giselle, Kambhampati Anita K, Hall Aron J, Ponce Diana, Galván Patricia, Tinoco Yeny O, Vinjé Jan, Parashar Umesh D, Mirza Sara A

机构信息

U.S. Naval Medical Research Unit SOUTH, Lima, Peru.

Division of Infectious Diseases, Department of Medicine, Walter Reed National Military Medical Center, Bethesda, Maryland.

出版信息

Am J Trop Med Hyg. 2025 Jan 7;112(4):921-927. doi: 10.4269/ajtmh.24-0331. Print 2025 Apr 2.

DOI:10.4269/ajtmh.24-0331
PMID:39773432
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11964828/
Abstract

Norovirus is the leading cause of acute gastroenteritis (AGE) globally. Few longitudinal studies have assessed norovirus-associated AGE incidence across age groups in community settings in Latin America. During April 2015-April 2019, active surveillance for AGE among community members of all ages was conducted through household visits two to three times per week in San Jeronimo, Cusco, Peru. An asymptomatic control household was selected for every fifth AGE case. Stool specimens were collected from AGE cases, asymptomatic household members, and control household members, and they were tested for norovirus using real-time reverse transcriptase polymerase chain reaction. Data on illness characteristics were collected from AGE cases during a 15-day follow-up period. Annual means of 247 households and 1,555 participants were enrolled during each April-March surveillance year, accounting for 4,176 person-years (PY) of observation. Of 1,099 AGE events reported, 1,014 stool specimens were tested, and 186 (18%) were norovirus positive. Norovirus AGE incidence was 4.4/100 PY (95% CI: 3.9-5.1); incidence was highest among those younger than 2 years old (60.9/100 PY; 95% CI: 46.8-79.4). Among 672 stool specimens from asymptomatic controls, 56 (8%) tested positive for norovirus. Odds of norovirus detection were significantly higher among cases compared with controls (odds ratio: 2.2; 95% CI: 1.6-3.1). Age-stratified norovirus incidence in this periurban community aligns with previously published estimates and was highest among those younger than 2 years old. Establishing baseline norovirus incidence in specific communities is crucial to identify target populations and assess effectiveness of future interventions, such as vaccines.

摘要

诺如病毒是全球急性胃肠炎(AGE)的主要病因。很少有纵向研究评估拉丁美洲社区环境中各年龄组诺如病毒相关的急性胃肠炎发病率。2015年4月至2019年4月期间,在秘鲁库斯科的圣赫罗尼莫,通过每周两到三次的家访,对所有年龄段的社区成员进行急性胃肠炎的主动监测。每五例急性胃肠炎病例选择一户无症状对照家庭。从急性胃肠炎病例、无症状家庭成员和对照家庭成员中采集粪便标本,并用实时逆转录聚合酶链反应检测诺如病毒。在15天的随访期内收集急性胃肠炎病例的疾病特征数据。在每个4月至次年3月的监测年度,共纳入247户家庭和1555名参与者的年度均值,观察人年数(PY)为4176。在报告的1099例急性胃肠炎事件中,检测了1014份粪便标本,其中186份(18%)诺如病毒呈阳性。诺如病毒急性胃肠炎发病率为4.4/100人年(95%CI:3.9 - 5.1);2岁以下儿童发病率最高(60.9/100人年;95%CI:46.8 - 79.4)。在672份无症状对照的粪便标本中,56份(8%)诺如病毒检测呈阳性。与对照相比,病例中诺如病毒检测的几率显著更高(优势比:2.2;95%CI:1.6 - 3.1)。这个城郊社区按年龄分层的诺如病毒发病率与先前发表的估计一致,且在2岁以下儿童中最高。确定特定社区的诺如病毒发病率基线对于确定目标人群和评估未来干预措施(如疫苗)的有效性至关重要。